Dragunsky EM - Search Results

1

RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence.

Chumakov KM, Norwood LP, Parker ML, Dragunsky EM, Ran YX, Levenbook IS. Chumakov KM, et al. Among authors: dragunsky em. J Virol. 1992 Feb;66(2):966-70. doi: 10.1128/JVI.66.2.966-970.1992. J Virol. 1992. PMID: 1309923 Free PMC article.

2

Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test.

Dragunsky E, Gardner D, Taffs R, Levenbook I. Dragunsky E, et al. Biologicals. 1993 Sep;21(3):233-7. doi: 10.1006/biol.1993.1080. Biologicals. 1993. PMID: 8117436

3

Assessment of the viral RNA sequence heterogeneity for control of OPV neurovirulence.

Chumakov K, Norwood L, Parker M, Dragunsky E, Taffs R, Ran Y, Ridge J, Levenbook I. Chumakov K, et al. Dev Biol Stand. 1993;78:79-89; discussion 88-9. Dev Biol Stand. 1993. PMID: 8388834

4

A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.

Dragunsky E, Taffs R, Chernokhvostova Y, Nomura T, Hioki K, Gardner D, Norwood L, Levenbook I. Dragunsky E, et al. Biologicals. 1996 Jun;24(2):77-86. doi: 10.1006/biol.1996.0010. Biologicals. 1996. PMID: 8889053

5

TgPVR21 mice for testing type-3 oral poliovirus vaccines: role of clinical observation and histological examination.

Dragunsky E, Chernokhvostova Y, Taffs R, Chumakov K, Gardner D, Asher D, Nomura T, Hioki K, Levenbook I. Dragunsky E, et al. Vaccine. 1997 Dec;15(17-18):1863-6. doi: 10.1016/s0264-410x(97)00142-4. Vaccine. 1997. PMID: 9413095

6

Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine.

Rezapkin GV, Alexander W, Dragunsky E, Parker M, Pomeroy K, Asher DM, Chumakov KM. Rezapkin GV, et al. Virology. 1998 Jun 5;245(2):183-7. doi: 10.1006/viro.1998.9191. Virology. 1998. PMID: 9636357 Free article.

7

Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993-1999.

Levenbook I, Dragunsky E, Pervikovc Y. Levenbook I, et al. Vaccine. 2000 Sep 15;19(2-3):163-6. doi: 10.1016/s0264-410x(00)00190-0. Vaccine. 2000. PMID: 10930668

8

Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.

Rezapkin GV, Norwood LP, Taffs RE, Dragunsky EM, Levenbook IS, Chumakov KM. Rezapkin GV, et al. Among authors: dragunsky em. Virology. 1995 Aug 20;211(2):377-84. doi: 10.1006/viro.1995.1420. Virology. 1995. PMID: 7645242 Free article.

9

Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.

Taffs RE, Chumakov KM, Rezapkin GV, Lu Z, Douthitt M, Dragunsky EM, Levenbook IS. Taffs RE, et al. Among authors: dragunsky em. Virology. 1995 Jun 1;209(2):366-73. doi: 10.1006/viro.1995.1268. Virology. 1995. PMID: 7778271 Free article.

10

Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine.

Rezapkin GV, Chumakov KM, Lu Z, Ran Y, Dragunsky EM, Levenbook IS. Rezapkin GV, et al. Among authors: dragunsky em. Virology. 1994 Jul;202(1):370-8. doi: 10.1006/viro.1994.1353. Virology. 1994. PMID: 8009849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters